Navigation Links
Morgellons Medical Conference Highlights New Research
Date:5/16/2013

Austin, TX (PRWEB) May 16, 2013

The Charles E. Holman Foundation (CEHF), a non-profit advocacy group for those suffering the rare medical condition Morgellons Disease, is pleased to announce the incredible success of the 6th Annual Morgellons Medical Conference that took place in April in Austin, TX. Attendees from the around the globe, including researchers, medical professionals and patients, gathered for the event titled, “Searching for the Uncommon Thread” to discuss new research and understanding of the condition.

Morgellons Disease (MD) is a somewhat mysterious medical condition that is characterized by the formation of unusual fibers within the skin. Patients with the condition will often describe symptoms including the sensation of something crawling on or within their skin. The multi-system illness includes slow-healing skin lesions often accompanied with overwhelming fatigue and an array of neurological deficits. The condition affects people of all ages and ethnic groups, worldwide. New research confirms the presence of spirochetal bacteria in tissue of MD patients indicating an infectious element.

"The CEHF has come a long way in the research and advocacy of Morgellons Disease. We encourage the sharing of empirical research. Our annual conference, the only professional meeting devoted to Morgellons Disease, was begun and continues each year for this purpose,” said Cindy Casey-Holman, RN, Dir. of The CEHF.

The 2-day conference was held at the Wyndham Garden Hotel & Woodward Conference Center in Austin, TX. The speakers for the event included Randy S. Wymore, Ph.D., Director of Research at OSU-CHS-CIMD (Center for the Investigation of Morgellons Disease) and two assistants from his research team who provided an update on their work in Tulsa; Canadian Microbiologist Marianne Middelveen who presented her latest research involving DNA confirmation of Borrelia within MD patients' specimens. Ms. Middelveen also stepped in for her husband, Parasitologist Robert Allan, to discuss parasites commonly associated with humans (zoonotic diseases). This was a highly engaging portion of the conference event demonstrating, from a parasitological & microbiological perspective, that parasitic morphology was inconsistent with the structure of specimens from Morgellons Disease. Eva Sapi, PhD from University of New Haven (CT), recently credited with being the first to demonstrate that Lyme spirochetes create their own complex biofilm, discussed her involvement with MD research including future DNA research plans. Dr. Peter Mayne, GP Dermatologist from Australia, discussed the clinical findings associated with MD and elaborated about the PCR analysis used in the most current DNA report revealing the Borrelia spirochete. Dr. Edward Kilbane, Psychiatrist from Stanford University, discussed Psychiatric symptoms and diagnosis as related to MD; Amelia M. Withington, MD, Psychiatrist from PA, gave an insightful accounting of her journey over the past 5 yrs as a physician dealing with Morgellons Disease. The official DVD of the conference will be available June 1, 2013. To order a copy of the DVD and learn more about the mystery disease, please visit thecehf.org.

About The Charles E. Holman Foundation
The Charles E. Holman Foundation, based in Austin, TX, is a 501(c) (3) nonprofit organization committed to advocacy and philanthropy in the battle against MD. The foundation was named for Charles E. Holman, a pioneer in the fight against Morgellons Disease and is led by Executive Director Cindy Casey-Holman, RN.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10740073.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anonymous Editing on Wikipedia Keeps Morgellons Sufferers in the Dark
2. Physician Groups Call for Fewer Medical Tests
3. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
4. CAM therapy combined with conventional medical care may improve treatment of lower back pain
5. Image share project gives patients and physicians anytime, anywhere access to medical images
6. Researchers determine vitamin D blood level for reducing major medical risks in older adults
7. Biomedical researchers receive Hartwell Foundation awards
8. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
9. Fitness in Middle Age Lowers Medical Costs Later: Study
10. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
11. Gene Tests May Not Drive Patients to More Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and ... pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO of ... Society’s 2015 CEO of the Year , helped lead the effort to raise ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders and post-traumatic stress ... women and men with eating disorders report a history of trauma, research suggests ... of an eating disorder. , At the 2016 iaedp Symposium, the workshop, ...
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth published data from ... type 2 diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels ... in public health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua ... on how healthcare companies can use newly released government data on populations and ... population and intervene and capture the value they create to succeed in new ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research ... U.S. require dental technicians to be certified or obtain continuing education. To increase ... the “What’s In Your Mouth?” campaign to inform dentists and patients about the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... and FAIRFIELD, N.J. , ... and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they ... development and commercialization rights for OPA-15406 in the U.S. ... also provides manufacturing rights.  OPA-15406 is a topical, non-steroidal ... atopic dermatitis. --> --> ...
(Date:2/8/2016)... -- --> --> ... Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) ... Gynecology) - Global Forecasts to 2020", published by MarketsandMarkets, ... period of 2015 to 2020. The market is expected ... 10.5% from 2015 to 2020. Browse 73 ...
(Date:2/8/2016)... , Feb. 8, 2016 In a historic vote among its ... to construct a medical cannabis cultivation facility and dispensary on tribal land ... New York as a provider for patients in the state,s ... as a provider for patients in the state,s Medical Cannabis ... (34) to approve the project and pursue designation from the ...
Breaking Medicine Technology: